Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed1
Recruiting1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06958796Phase 4Recruiting
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
CytomegalovirusKidney Transplant; ComplicationsLiver Transplant Complications+2 more
PrincipalinvestigatorStart date: 2025-11-27
NCT06336863Not ApplicableEnrolling By Invitation
Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Kidney Transplant Immunosuppression
PrincipalinvestigatorStart date: 2024-06-14
NCT04786067Phase 4Completed
Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Kidney Transplant Immunosuppression
PrincipalinvestigatorStart date: 2021-07-28

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Camille Kotton, MD, FIDSA, FAST

Massachusetts General Hospital

Similar
1 trials

Shared therapeutic areas:

CytomegalovirusKidney Transplant; ComplicationsLiver Transplant; Complications+2 more

Worked with same sponsors:

Camille N. Kotton, MDKamada, Ltd.+1 more
Collaborated on 1 trial
Similarity Score54%

Cyrus Feizpour, MD

University of Texas Southwestern Medical Center

Related
1 trials

Shared therapeutic areas:

Kidney Transplant Immunosuppression

Worked with same sponsors:

CareDxUniversity of Texas Southwestern Medical Center
Collaborated on 1 trial
Similarity Score14%

Sunil K Saini, MSc, PhD

Department of Health Technology, Technical University of Denmark

Related
2 trials

Shared therapeutic areas:

Kidney Transplant; ComplicationsLiver Transplant; Complications
Similarity Score10%

Annemette Hald, RN

Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

Related
2 trials

Shared therapeutic areas:

Kidney Transplant; ComplicationsLiver Transplant; Complications
Similarity Score10%

Zitta B Harboe, MD, PhD

Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital - North Zealand

Related
1 trials

Shared therapeutic areas:

Kidney Transplant; Complications
Similarity Score5%

Claus Bistrup, MD, PhD

Department of Nephrology, Odense University Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Transplant; Complications
Similarity Score5%

Susan Prockop, MD

Memorial Sloan Kettering Cancer Center

Related
7 trials

Shared therapeutic areas:

Cytomegalovirus
Similarity Score5%

Susanne D Nielsen, MD, DMSc

Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet

Related
1 trials

Shared therapeutic areas:

Kidney Transplant; Complications
Similarity Score5%

Hao Feng, MD., Ph.D.

Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU

Related
3 trials

Shared therapeutic areas:

Liver Transplant; Complications
Similarity Score5%

Henrik Birn, MD, PhD, DMSc

Department of Nephrology, Aarhus University Hospital

Related
1 trials

Shared therapeutic areas:

Kidney Transplant; Complications
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06958796Phase 4PrincipalInvestigator

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

CytomegalovirusKidney Transplant; ComplicationsLiver Transplant Complications+2 more
Recruiting
NCT06336863Not ApplicablePrincipalInvestigator

Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

Kidney Transplant Immunosuppression
Enrolling By Invitation
NCT04786067Phase 4PrincipalInvestigator

Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

Kidney Transplant Immunosuppression
Completed

All 3 trials loaded